Literature DB >> 27306595

Impact of informing donors of low ferritin results.

Mindy Goldman1, Samra Uzicanin2, Jenna Scalia2, Vito Scalia3, Sheila F O'Brien2.   

Abstract

BACKGROUND: Informing donors of their ferritin status is one possible mitigating strategy to reduce iron deficiency in donors. STUDY DESIGN AND METHODS: We evaluated the impact of informing donors of their ferritin status on their donation frequency, understanding of iron needs, and actions to improve iron intake 2 years after their inclusion in a prospective observational cohort study.
RESULTS: Informing donors of low ferritin results decreased return rate in first-time and repeat donors, and the median number of donations declined from three to two donations/year in returning donors with low ferritin on index donation compared to an increase from 1.5 to 2.5 donations/year in donors with normal ferritin. An electronic questionnaire demonstrated that approximately 60% of low ferritin donors saw their primary medical practitioner, and half of this group started iron. Qualitative interviews revealed suboptimal understanding of iron needs and poor compliance with iron supplementation.
CONCLUSION: Providing donors with results of ferritin testing may reduce return rates and donation frequency in the 2 years after testing. Simply providing donors with ferritin results and an information sheet is often inadequate to improve donors' understanding of iron needs and may not lead to a substantive increase in iron intake over time.
© 2016 AABB.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27306595     DOI: 10.1111/trf.13691

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  2 in total

1.  The operational implications of donor behaviors following enrollment in STRIDE (Strategies to Reduce Iron Deficiency in blood donors).

Authors:  Ritchard G Cable; Rebecca J Birch; Bryan R Spencer; David J Wright; Walter Bialkowski; Joseph E Kiss; Jorge Rios; Barbara J Bryant; Alan E Mast
Journal:  Transfusion       Date:  2017-07-13       Impact factor: 3.157

2.  Longer-term efficiency and safety of increasing the frequency of whole blood donation (INTERVAL): extension study of a randomised trial of 20 757 blood donors.

Authors:  Stephen Kaptoge; Emanuele Di Angelantonio; Carmel Moore; Matthew Walker; Jane Armitage; Willem H Ouwehand; David J Roberts; John Danesh; Simon G Thompson
Journal:  Lancet Haematol       Date:  2019-08-02       Impact factor: 30.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.